Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Americas BioTech is a biotechnology company based in Miami, Florida, specializing in the development and distribution of advanced regenerative medicine products. The company’s portfolio includes stem cell-derived exosomes, amniotic fluid, and umbilical cord-derived tissues, which are designed to promote tissue repair and modulate inflammatory responses. These biologic therapies are primarily utilized in clinical applications for orthopedics, pain management, wound care, and aesthetic medicine. Americas BioTech focuses on providing high-quality, minimally manipulated cellular and acellular therapies to healthcare providers globally. By leveraging the innate healing properties of perinatal biologics, the company aims to address a wide range of degenerative and chronic conditions through non-surgical alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Americas BioTech.